Evaluation of Allplex™ Entero-DR assay for detection of antimicrobial resistance determinants from bacterial cultures

[1] Rogers Van Katwyk S(2017)Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis Syst Rev 6 256-1596

[2] Grimshaw JM(2006)Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589-5641

[3] Mendelson M(2005)Evaluation of techniques for detection of carbapenem-resistant J Clin Microbiol 43 5639-S13

[4] Taljaard M(2018) in stool surveillance cultures J Clin Microbiol 6 S5-398

[5] Hoffman SJ(2019)Phenotypic detection of carbapenemase-producing organisms from clinical isolates Open Forum Infect Dis 23 388-S36

[6] Kumar A(2019)Antimicrobial resistance surveillance and new drug development Infect 215 S28-433

[7] Roberts D(2017)Carbapenemase-producing Enterobacteriaceae: a diagnostic, epidemiological and therapeutic challenge J Infect Dis 3 421-1236

[8] Wood KE(2012)The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace Virulence 12 1221-108

[9] Light B(2019)Intrinsic and acquired resistance mechanisms in enterococcus Probiotics Antimicrob Proteins 14 95-2425

[10] Parrillo JE(2014)The Increasing Issue of vancomycin-resistant Enterococci and the bacteriocin solution Expert Rev Anti Infect Ther 59 2421-1297

[1] Rogers Van Katwyk S(2017)Government policy interventions to reduce human antimicrobial use: protocol for a systematic review and meta-analysis Syst Rev 6 256-1596

[2] Grimshaw JM(2006)Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock Crit Care Med 34 1589-5641

[3] Mendelson M(2005)Evaluation of techniques for detection of carbapenem-resistant J Clin Microbiol 43 5639-S13

[4] Taljaard M(2018) in stool surveillance cultures J Clin Microbiol 6 S5-398

[5] Hoffman SJ(2019)Phenotypic detection of carbapenemase-producing organisms from clinical isolates Open Forum Infect Dis 23 388-S36

[6] Kumar A(2019)Antimicrobial resistance surveillance and new drug development Infect 215 S28-433

[7] Roberts D(2017)Carbapenemase-producing Enterobacteriaceae: a diagnostic, epidemiological and therapeutic challenge J Infect Dis 3 421-1236

[8] Wood KE(2012)The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace Virulence 12 1221-108

[9] Light B(2019)Intrinsic and acquired resistance mechanisms in enterococcus Probiotics Antimicrob Proteins 14 95-2425

[10] Parrillo JE(2014)The Increasing Issue of vancomycin-resistant Enterococci and the bacteriocin solution Expert Rev Anti Infect Ther 59 2421-1297